Francesco Gentile

Dr. Francesco Gentile

Neuromuscular and neuroimmunology service, Humanitas Clinical Institute IRCCS
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FGFrancesco Gentile
Francesco Gentile
PDPietro Emiliano Doneddu
Pietro Emiliano Doneddu
NRNilo Riva
Nilo Riva
ENEduardo Nobile-Orazio
Eduardo Nobile-Orazio
AQAngelo Quattrini
Angelo Quattrini
Increasing evidence gives support for the idea that extra-neuronal factors may affect brain physiology and its predisposition to neurodegenerative diseases. Epidemiological and experimental studies show that nutrition and metabolic disorders such as obesity and type 2 diabetes increase the risk of Alzheimer’s and Parkinson’s diseases after midlife, while the relationship with amyotrophic lateral sclerosis is uncertain, but suggests a protective effect of features of metabolic syndrome. The microbiota has recently emerged as a novel factor engaging strong interactions with neurons and glia, deeply affecting their function and behavior in these diseases. In particular, recent evidence suggested that gut microbes are involved in the seeding of prion-like proteins and their spreading to the central nervous system. Here, we present a comprehensive review of the impact of metabolism, diet and microbiota in neurodegeneration, by affecting simultaneously several aspects of health regarding energy metabolism, immune system and neuronal function. Advancing technologies may allow researchers in the future to improve investigations in these fields, allowing the buildup of population-based preventive interventions and development of targeted therapeutics to halt progressive neurologic disability.

25 June 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
FGFrancesco Gentile
Francesco Gentile
SSStefania Scarlino
Stefania Scarlino
YFYuri Matteo Falzone
Yuri Matteo Falzone
CLChristian Lunetta
Christian Lunetta
LTLucio Tremolizzo
Lucio Tremolizzo
NRNilo Riva
Nilo Riva
Although amyotrophic lateral sclerosis (ALS) has been considered as a disorder of the motor neuron (MN) cell body, recent evidences show the non-cell-autonomous pathogenic nature of the disease. Axonal degeneration, loss of peripheral axons and destruction of nerve terminals are early events in the disease pathogenic cascade, anticipating MN degeneration, and the onset of clinical symptoms. Therefore, although ALS and peripheral axonal neuropathies should be differentiated in clinical practice, they also share damage to common molecular pathways, including axonal transport, RNA metabolism and proteostasis. Thus, an extensive evaluation of the molecular events occurring in the peripheral nervous system (PNS) could be fundamental to understand the pathogenic mechanisms of ALS, favoring the discovery of potential disease biomarkers, and new therapeutic targets.

24 November 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
GLGiuseppe Liberatore
Giuseppe Liberatore
TSTiziana De Santis
Tiziana De Santis
PDPietro Emiliano Doneddu
Pietro Emiliano Doneddu
FGFrancesco Gentile
Francesco Gentile
AAAlberto Albanese
Alberto Albanese
ENEduardo Nobile-Orazio
Eduardo Nobile-Orazio

29 May 2020 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
PDPietro Emiliano Doneddu
Pietro Emiliano Doneddu
DMDaniele Mandia
Daniele Mandia
FGFrancesco Gentile
Francesco Gentile
FGFrancesca Gallia
Francesca Gallia
GLGiuseppe Liberatore
Giuseppe Liberatore
ENEduardo Nobile-Orazio
Eduardo Nobile-Orazio

9 June 2020 in Journal of Synchrotron Radiation
Verified
Journal Article
Open access
PDF file
GPGinevra Begani Provinciali
Ginevra Begani Provinciali
NPNicola Pieroni
Nicola Pieroni
IBInna Bukreeva
Inna Bukreeva
MFMichela Fratini
Michela Fratini
LMLorenzo Massimi
Lorenzo Massimi
ACAlessia Cedola
Alessia Cedola
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting motor neurons. Pre-clinical studies drive the development of animal models that well mimic ALS disorder and enable both the dissection of disease processes and an early assessment of therapy efficacy. A comprehensive knowledge of neuronal and vascular lesions in the brain and spinal cord is an essential factor to understand the development of the disease. Spatial resolution and bidimensional imaging are important drawbacks limiting current neuroimaging tools, while neuropathology relies on protocols that may alter tissue chemistry and structure. In contrast, recent ex vivo studies in mice demonstrated that X-ray phase-contrast tomography enables study of the 3D distribution of both vasculature and neuronal networks, without sample sectioning or use of staining. Here we present our findings on ex vivo SOD1G93A ALS mice spinal cord at a micrometric scale. An unprecedented direct quantification of neuro-vascular alterations at different stages of the disease is shown.

21 March 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
FGFrancesco Gentile
Francesco Gentile
TBTommaso Bocci
Tommaso Bocci
SCSilvia Coppola
Silvia Coppola
TPTommaso Pozzi
Tommaso Pozzi
LMLeo Modafferi
Leo Modafferi
Davide ChiumelloDavide Chiumello
Davide Chiumello
The emergence of SARS-CoV-2 and its related disease caused by coronavirus (COVID-19) has posed a huge threat to the global population, with millions of deaths and the creation of enormous social and healthcare pressure. Several studies have shown that besides respiratory illness, other organs may be damaged as well, including the heart, kidneys, and brain. Current evidence reports a high frequency of neurological manifestations in COVID-19, with significant prognostic implications. Importantly, emerging literature is showing that the virus may spread to the central nervous system through neuronal routes, hitting the brainstem and cardiorespiratory centers, potentially exacerbating the respiratory illness. In this systematic review, we searched public databases for all available evidence and discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19. Acknowledging the involvement of these primordial brain areas in the pathogenesis of the disease may fuel research on the topic and allow the development of new therapeutic strategies.